Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 3/20 | 0.69 |
| ▸ | MMP2 | P08253 | 5/20 | 0.67 |
| ▸ | MMP9 | P14780 | 5/20 | 0.67 |
| ▸ | MMP8 | P22894 | 5/20 | 0.67 |
| ▸ | MMP13 | P45452 | 5/20 | 0.67 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | PRSS12 | P56730 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14381554 | 1.00 | HPSE (0.69) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381858 | 1.00 | HPSE (0.69) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381521 | 0.98 | MMP2 (0.71) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381764 | 0.95 | HPSE (0.67) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381525 | 0.95 | HPSE (0.67) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381542 | 0.93 | MMP2 (0.77) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL6128131 | 0.91 | HPSE (0.65) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381922 | 0.90 | HPSE (0.61) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381565 | 0.90 | CHEK2 (0.66) | HPSEMMP2MMP9MMP8MMP13 | |
| SCHEMBL14381562 | 0.90 | KDM4E (0.76) | HPSEMMP2MMP9MMP8MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7282518-B2 | Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation | AVANIR PHARMACEUTICALS (US) | 2007-10-16 | — | — | US | disclosed |
| US-7282518-B2 | Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation | AVANIR PHARMACEUTICALS (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070202133-A1 | BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION | SIRCAR JAGADISH C | 2007-08-30 | — | — | US | disclosed |
| US-20070202133-A1 | BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION | SIRCAR JAGADISH C | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070202133-A1 | BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION | MKI67, CMA1, CCNI | HPSE 4488/4885MMP2 760/4885MMP9 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.